Invivyd Inc. (IVVD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $158.49M
Last updated: Nov 17, 2026 at 4:33 PM ET
Invivyd Inc. (IVVD) Statistics
Invivyd (IVVD) has a market cap of $158.49M and an enterprise value of $32.09M. Its share count is up 89.48% from a year earlier. It kept -214.77% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 79.75% below the market cap, as cash exceeds debt.
| Market Cap | $158.49M |
|---|---|
| Enterprise Value | $32.09M |
| Latest price (Nov 17, 2026) | $0.51 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 16, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.7x and 1.1x. Its year-end P/S ranged from 2.1x to 143.1x from 2023 to 2025.
| P/S Ratio | 2.7x |
|---|---|
| Forward P/S | 2.6x |
| P/B Ratio | 1.1x |
Price Statistics
The stock is down 78.19% over 52 weeks and trades 28.17% below its 50-day average.
| Beta (1Y) | 2.10 |
|---|---|
| 52-Week Change | -78.19% |
| 1-Month Change | -15.97% |
| 3-Month Change | -46.58% |
| 6-Month Change | -50.71% |
| 5-Year Change | -98.01% |
| Total Return (1Y) | -78.19% |
| Total Return (3Y CAGR) | -29.12% |
| Total Return (5Y CAGR) | -51.73% |
| Max Drawdown (1Y) | -82.20% |
| Max Drawdown (3Y) | -92.90% |
| Sharpe Ratio (1Y) | -1.63 |
| Correlation with SPY (1Y) | 0.29 |
| 50-Day Average | $0.71 |
| 200-Day Average | $1.07 |
| 52-Week Range | $0.52 to $3.01 |
| RSI (14 Days) | 35.7 |
| Average Volume (20 Days) | 4.01M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.51x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 5.51x |
|---|---|
| Quick Ratio | 5.51x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -86.61% over the last 12 months, against a 5-year average of -98.74%.
| Return on Equity (ROE) | -86.61% |
|---|---|
| Return on Assets (ROA) | -70.87% |
| Return on Capital Employed (ROCE) | -82.97% |
| ROE (5Y Average) | -98.74% |
| ROA (5Y Average) | -67.28% |
| ROIC (5Y Average) | -17.17% |
| Asset Turnover | 0.38x |
| Receivables Turnover | 5.18x |
Scores
IVVD has an Altman Z-Score of -6.43, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -6.43 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $60.69M over the last 12 months is up 21.28% from the 12 months before.
| Revenue | $60.69M |
|---|---|
| Revenue Growth (YoY) | +21.28% |
| Gross Profit | $56.20M |
| Operating Income | -$136.19M |
| Pretax Income | -$130.33M |
| Net Income | -$130.33M |
| EBITDA | -$128.10M |
| EBIT | -$130.33M |
| Reported EPS (TTM) | -$0.41 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 81.82% of the $183.91M in total assets.
| Cash and Equivalents | $126.40M |
|---|---|
| Total Debt | $0 |
| Net Cash | $126.40M |
| Net Cash Per Share | $0.39 |
| Working Capital | $121.03M |
| Shareholder Equity | $150.48M |
| Book Value Per Share | $0.47 |
| Total Assets | $183.91M |
| Total Liabilities | $33.42M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.82M of capital spending, operating cash flow left -$134.11M of free cash flow.
| Operating Cash Flow | -$132.29M |
|---|---|
| Capital Expenditures | $1.82M |
| Free Cash Flow | -$134.11M |
| FCF Per Share | -$0.45 |
| Depreciation and Amortization | $2.23M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -224.42%.
| Gross Margin | 92.60% |
|---|---|
| Operating Margin | -224.42% |
| Pretax Margin | -214.77% |
| Net Margin | -214.77% |
| EBITDA Margin | -211.08% |
| EBIT Margin | -214.77% |
| FCF Margin | -220.99% |
Growth
| Book Value Per Share Growth (2Y CAGR) | -6.82% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -6.82% |
Dividends and Yields
IVVD does not pay a dividend.
| Buyback Yield | -78.01% |
|---|---|
| Shareholder Yield | -78.01% |
Peer Position
Against 8 similar companies, IVVD has the 8th highest P/S.
P/S RatioPeer median 14.9x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -33.45%
| P/S Ratio | 2.7x vs 14.9x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +21.28% vs -33.45% median |
Analyst Forecast
Consensus estimates put revenue growth at 27.60% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +27.60% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IVVD
What is IVVD's market cap?
Invivyd has a market cap of $158.49M. Its enterprise value, which adds debt and subtracts cash, is $32.09M.
How many shares of IVVD are outstanding?
Invivyd has 322.43M shares outstanding. The count is up 89.48% from a year earlier.
Does IVVD pay a dividend?
No. Invivyd does not pay a dividend.
How much debt does IVVD have?
Invivyd has $0 of total debt and $126.40M of cash and equivalents, a net cash position of $126.40M.
IVVD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors